Not applicableUnknownNCT03795506What this trial is testingTLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)Who this might be right forAtopic Dermatitis Eczema Imperial College London 96
Testing effectiveness (Phase 2)Study completedNCT06713499What this trial is testingA Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic DermatitisWho this might be right forChildren and Adolescents With Moderate-to-severe Atopic Dermatitis Guangdong Hengrui Pharmaceutical Co., Ltd 51
Early research (Phase 1)Study completedNCT03826901What this trial is testingDelgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and ChildrenWho this might be right forAtopic Dermatitis LEO Pharma 46
Large-scale testing (Phase 3)Study completedNCT03952559What this trial is testingBaricitinib (LY3009104) in Children and Adolescents With Atopic DermatitisWho this might be right forAtopic Dermatitis Eli Lilly and Company 516
Testing effectiveness (Phase 2)Study completedNCT06324812What this trial is testingEvaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic DermatitisWho this might be right forDermatitis, Atopic Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 128
Testing effectiveness (Phase 2)Study completedNCT05579925What this trial is testingCM310 in Children Patients With Moderate-to-severe Atopic DermatisWho this might be right forAtopic Dermatitis Keymed Biosciences Co.Ltd 24